National Cancer Institute "Cancer Moonshot Biobank" (NCT04314401)
🩺 Plain-English Summary (8th-Grade Level)
This trial collects multiple tissue and blood samples, along with medical information, from cancer patients. The "Cancer Moonshot Biobank" is a longitudinal study. This means it collects and stores samples and information over time, throughout the course of a patient's cancer treatment. By looking at samples and information collected from the same people over time, researchers hope to better understand how cancer changes over time and over the course of medical treatments.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (49 items) and avoid the listed exclusions (16 items).
Location: Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis — Daphne, Alabama
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria:
- Treated with or has already begun treatment with a non-standard of care therapeutic agent (investigational) in an interventional clinical trial
- For the purposes of this study, past enrollment in clinical trials whereby the patient was randomized and treated with standard-of-care anti-cancer treatment (chemotherapy regimen, surgery and radiation therapy) is allowed
- Uncontrolled intercurrent illness that in the physician's assessment would pose undue risk for biopsy
- Use of full dose coumarin-derivative anticoagulants such as warfarin are prohibited. Patients may be switched to low molecular weight (LMW) heparin at physician discretion
- Low molecular weight (LMW) heparin is permitted for prophylactic or therapeutic use
- Factor X inhibitors are permitted
- Use of anti-platelet drugs are permitted
- Stopping the anticoagulation treatment for biopsy, bone marrow aspirate, or resection should be per site standard operating procedure (SOP)
- NCI PDMR EXCLUSION CRITERIA: Patients with complete response
- NCI PDMR EXCLUSION CRITERIA: Patients with invasive fungal infections
- NCI PDMR EXCLUSION CRITERIA: Patients with active and/or uncontrolled infections or who are still recovering from an infection
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (150 Sites)
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Malbis — Daphne, Alabama
- Thomas Hospital — Fairhope, Alabama
- Mobile Infirmary Medical Center — Mobile, Alabama
- Gulf Health Hospitals Inc/Infirmary Cancer Care - Saraland — Saraland, Alabama
- Kingman Regional Medical Center — Kingman, Arizona
- Mercy Hospital Fort Smith — Fort Smith, Arkansas
- PCR Oncology — Arroyo Grande, California
- AIS Cancer Center at San Joaquin Community Hospital — Bakersfield, California
- Veterans Affairs Loma Linda Healthcare System — Loma Linda, California
- Salinas Valley Memorial — Salinas, California
- Intermountain Health Platte Valley Hospital — Brighton, Colorado
- Saint Joseph Hospital - Cancer Centers of Colorado — Denver, Colorado
- Lutheran Hospital - Cancer Centers of Colorado — Golden, Colorado
- Saint Mary's Hospital and Regional Medical Center — Grand Junction, Colorado
- Good Samaritan Hospital - Cancer Centers of Colorado — Lafayette, Colorado
- Hartford Hospital — Hartford, Connecticut
- Bayhealth Hospital Kent Campus — Dover, Delaware
- Bayhealth Hospital Sussex Campus — Milford, Delaware
- Boca Raton Regional Hospital — Boca Raton, Florida
- Broward Health North — Deerfield Beach, Florida
- Broward Health Medical Center — Fort Lauderdale, Florida
- Tampa General Hospital — Tampa, Florida
- Northside Hospital — Atlanta, Georgia
- Lewis Cancer and Research Pavilion at Saint Joseph's/Candler — Savannah, Georgia
- Illinois CancerCare-Bloomington — Bloomington, Illinois
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.